Key facts
- Occuity’s last known valuation is $44.7M (Feb 2026).
- It has raised $19.5M.
- Notable investors include Innovate UK, Longevitytech.fund, Thames Valley Berkshire Local Enterprise Partnership.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Occuity
- ·The full record, as it builds
Funding rounds
No funding rounds for Occuity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Occuity
Developer of non-contact optical instruments designed for optometry or other optical measurements, as well as disease diagnosis and monitoring through the eye. The company's instruments enable direct eye measurements for optometrists and ophthalmologists, and other more general health conditions such as diabetes and Alzheimer's Disease to be monitored, enabling healthcare professionals to improve the effectiveness and accessibility of diagnostic and screening technology.
- Sector
- Healthcare
- HQ
- Reading, United Kingdom
- Founded
- 2019
- Employees
- 43
- Website
- occuity.com/
- Ownership
- Privately Held (backing)
Occuity doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Occuity shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Occuity in its N-PORT filings yet. We sweep new filings monthly.